Brain Tumor Awareness Month is a powerful reminder that children with brain tumors deserve more. More time being kids, more days at home instead of at the hospital, more moments of childhood joy. Working together, we can bring them and their families hope - for more time, more milestones, and more memories. #CommittedFromDayOne #BrainTumorAwarenessMonth #BTAM
Day One Biopharmaceuticals
Biotechnology Research
Brisbane, California 24,360 followers
Redefining hope from Day One.
About us
Day One Biopharmaceuticals is a commercial-stage company focused on advancing first- or best-in-class medicines for childhood and adult diseases with equal intensity. We were founded to address the lack of new therapies resulting from the traditional drug development model, which has left children with cancer and their families waiting too long for new treatments. At Day One, we aim to identify and develop breakthrough medicines with the goal of improving the outcomes and life trajectories of patients of any age facing serious diseases — starting from Day One. Our “search & development” strategy enables us to find, acquire, and develop potential best-or first-in-class programs with the goal of introducing new medicines that will make a real difference in the treatment of children and adults.
- Website
-
http://www.dayonebio.com
External link for Day One Biopharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Brisbane, California
- Type
- Public Company
- Founded
- 2018
- Specialties
- Oncology, Cancer, Drug Development, Biotechnology, Pediatric Oncology, Targeted Therapies, MAPK, Neuro-Oncology, Glioma, Childhood Cancer, Translational Medicine, Hematology, and Glioma
Locations
-
Primary
1800 Sierra Point Pkwy
Brisbane, California 94005, US
Employees at Day One Biopharmaceuticals
Updates
-
The Day One team is at the Society for Neuro-Oncology Pediatric Neuro-Oncology Conference in San Diego, looking forward to connecting with the childhood cancer community and experts in the field. If you are attending #SNOPeds2025, stop by booth 33/34 to say hello!
-
-
Day One is looking forward to welcoming the Pediatric Neuro-Oncology community to the 2025 SNO Pediatric Neuro-Oncology Conference later this week! Connect with peers at our reception on 5/15 and hear from Day One leaders on the collaboration between academia and industry to advance drug development. Learn more and register here: https://bit.ly/4j8ztwd
-
-
Day One's Talent Acquisition team is looking forward to meeting you at Biocom California Life Science Career Expo on May 14th! We are thrilled to have the opportunity to join leading employers in our industry for this exciting event that includes a job fair and educational sessions for job seekers. Learn more here: https://bit.ly/4d4MVzt Jenny Lash and Ryan Sanders can't wait to meet you there!
-
-
We're on a mission to advance first-or best-in-class medicines for childhood and adult diseases and we would like dedicated professionals to join us. Apply below or share with your network! 𝐒𝐞𝐧𝐢𝐨𝐫 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫, 𝐄𝐯𝐢𝐝𝐞𝐧𝐜𝐞 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐏𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬: https://bit.ly/3F2Vhev 𝐒𝐞𝐧𝐢𝐨𝐫 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫, 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐝 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐬: https://bit.ly/4jOIDiu 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫, 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲: https://bit.ly/3YCh6YX #WeAreHiring #BiopharmaJobs #CommittedFromDayOne
-
The Day One team is excited to be at the 2025 American Society of Pediatric Hematology/Oncology (ASPHO) Conference in Louisville this week! Stop by our booth 113 to hear how we're redefining what's possible for people of all ages living with cancer. Learn more about our mission here: https://lnkd.in/g2DUj4mk #ASPHO2025
-
-
Day One reports first quarter 2025 financial results. Read more: https://bit.ly/3Smr6Sr
-
-
Nurses play a crucial role in pediatric oncology - whether at the bedside, in a clinical trial, or behind the scenes in drug development. During National Nurses Week, we celebrate the nurses who bring their deep clinical knowledge, empathy, and advocacy to patients and their families. We are proud to work alongside nurses whose unwavering commitment continues to shape a more hopeful future for patients. #NursesWeek2025 #ThePowerofNurses
-
Every day, children and families face the life-changing reality of a brain tumor diagnosis, the most common solid tumor in pediatric patients and some of the hardest to treat. During #BrainTumorAwarenessMonth, we’re committed to shining a light on the profound impact brain tumors have on children and their families, and the crucial need for more research, treatment options, and support. Join us in raising awareness as we #GoGrayInMay.
-
-
We’re proud to share that Day One’s CEO, Jeremy Bender, has been named to The Medicine Maker Power List 2025! This recognition honors leaders accelerating progress across drug development. Under Jeremy’s leadership, we’re building a sustainable company while reshaping drug development so children and adults facing cancer do not have to wait so long for new medicines to be available. View the full list here: https://bit.ly/4jZzMKC
-